pancreatic cancer mortality

Pancreatic cancer is a highly malignant digestive tract tumor, and its mortality rate remains high worldwide. The disease is known for its insidious onset, rapid progression, and extremely high mortality.

Pancreatic cancer has an extremely high mortality rate, mainly due to low early diagnosis rates and poor treatment outcomes. Due to the deep location of the pancreas, early symptoms are not obvious. Many patients are already in the middle and late stages when diagnosed and miss the best opportunity for treatment. According to the latest statistics from the World Health Organization's International Agency for Research on Cancer, the 5 annual survival rate of pancreatic cancer is extremely low, only about 5%, which is far lower than the survival rate of other common cancers. This means that only a very small number of pancreatic cancer patients will survive within 55 years of diagnosis.

Looking more broadly, pancreatic cancer survival rates remain worrisome, although overall cancer survival rates have improved. Nearly 10 out of 100 people (nearly 10%) survive cancer for 5 years or more, but this ratio is significantly reduced among patients with pancreatic cancer. It is estimated that only 5 in 100 people (5%) survive cancer for 10 years or more after diagnosis, and even fewer pancreatic cancer patients achieve this rate.

The reason why the mortality rate of pancreatic cancer is so high is closely related to the difficulty of treatment and the degree of malignancy. Pancreatic cancer is extremely malignant. Tumor cells grow rapidly and easily invade surrounding tissues and blood vessels, making surgical resection difficult and the recurrence rate high. At the same time, pancreatic cancer is less sensitive to chemotherapy and radiotherapy, and the treatment effect is limited. Together, these factors contribute to the high mortality rate from pancreatic cancer.

Therefore, the prevention, early detection and effective treatment of pancreatic cancer are particularly important. By strengthening health education, improving early diagnosis rates, optimizing treatment plans and other measures, it is expected to reduce the mortality rate of pancreatic cancer and improve patients' survival rate and quality of life.

(Click to view an introduction to drugs for the treatment of pancreatic cancer)

xa0

Reference materials:https://www.cancerresearchuk.org/about-cancer/pancreatic-cancer/survival